Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

Netherlands

Marieke van de Belt, Amsterdam

OLVG, Amsterdam

Catharina Ziekenhuis, Eindhoven

Spaarne Ziekenhuis, Haarlem

Tergooi, Hilversum

Haga ziekenhuis, The Hague